Literature DB >> 12724049

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.

John M Flack1, Samar A Nasser.   

Abstract

Entities:  

Year:  2003        PMID： 12724049     DOI： 10.1007/s11906-003-0019-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  10 in total

1.  Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.

Authors: 
Journal:  J Hypertens       Date:  1997-02       Impact factor: 4.844

2.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

Authors:  L Hansson; L H Lindholm; T Ekbom; B Dahlöf; J Lanke; B Scherstén; P O Wester; T Hedner; U de Faire
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

3.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Authors:  B Neal; S MacMahon; N Chapman
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

4.  Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials.

Authors:  M Pahor; B M Psaty; M H Alderman; W B Applegate; J D Williamson; C Cavazzini; C D Furberg
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

5.  A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.

Authors:  E Saunders; M R Weir; B W Kong; J Hollifield; J Gray; V Vertes; J R Sowers; M B Zemel; C Curry; J Schoenberger
Journal:  Arch Intern Med       Date:  1990-08

Review 6.  Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damage.

Authors:  J M Flack; G A Mensah; C M Ferrario
Journal:  Curr Med Res Opin       Date:  2000       Impact factor: 2.580

7.  Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators.

Authors:  S G Chrysant; A B Weder; D A McCarron; M Canossa-Terris; J D Cohen; P A Gunter; B P Hamilton; A J Lewin; R F Mennella; L W Kirkegaard; M R Weir; M H Weinberger
Journal:  Am J Hypertens       Date:  2000-11       Impact factor: 2.689

8.  Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

Authors:  R O Estacio; B W Jeffers; N Gifford; R W Schrier
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

9.  Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  B J Materson; D J Reda; W C Cushman; B M Massie; E D Freis; M S Kochar; R J Hamburger; C Fye; R Lakshman; J Gottdiener
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

10.  Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone.

Authors:  Linda B Piller; Barry R Davis; Jeffrey A Cutler; William C Cushman; Jackson T Wright; Jeff D Williamson; Frans HH Leenen; Paula T Einhorn; Otelio S Randall; John S Golden; L Julian Haywood
Journal:  Curr Control Trials Cardiovasc Med       Date:  2002-11-14
  10 in total
  2 in total

1.  Comparison of the Effect of Thiazide Diuretics and Other Antihypertensive Drugs on Central Blood Pressure: Cross-Sectional Analysis Among Nondiabetic Patients.

Authors:  Cristiano S Moura; Stella S Daskalopoulou; Linda E Levesque; Sasha Bernatsky; Michal Abrahamowicz; Meytal A Tsadok; Shadi Rajabi; Louise Pilote
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-20       Impact factor: 3.738

2.  First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care.

Authors:  Sarah-Jo Sinnott; Ian J Douglas; Liam Smeeth; Elizabeth Williamson; Laurie A Tomlinson
Journal:  BMJ       Date:  2020-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.